copper bis-3,5-diisopropylsalicylate

Suppliers

Names

[ CAS No. ]:
21246-18-4

[ Name ]:
copper bis-3,5-diisopropylsalicylate

[Synonym ]:
bis(3,5-diisopropylsalicylato)-coppe
COPPER(II)3,5-DIISOPROPYLSALICYLICACID
Cu(II)(dps)2
copper(II) 3,5-diisopropylsalicylate
Cu(II)(3,5-diisopropylsalicylate)2
COPPER-3,5-DIISOPROPYLSALICYLATE

Chemical & Physical Properties

[ Molecular Formula ]:
C26H34CuO6

[ Molecular Weight ]:
506.09100

[ Exact Mass ]:
505.16500

[ PSA ]:
120.72000

[ LogP ]:
4.00250

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
GL6483500
CHEMICAL NAME :
Copper, bis(3,5-diisopropylsalicylato)-
CAS REGISTRY NUMBER :
21246-18-4
LAST UPDATED :
199707
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C26-H34-Cu-O6
MOLECULAR WEIGHT :
506.14
WISWESSER LINE NOTATION :
1Y1&R BQ CVO EY1&1 2 &-CU-

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
240 mg/kg
TOXIC EFFECTS :
Musculoskeletal - joints Tumorigenic - active as anti-cancer agent Biochemical - Metabolism (Intermediary) - effect on inflammation or mediation of inflammation
REFERENCE :
PMDCAY Progress in Medical Chemistry. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1961- Volume(issue)/page/year: 15,211,1977
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
253 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
RTCPA3 Recueil des Travaux Chimiques des Pays-Bas. Journal of the Royal Netherlands Chemical Society. (The Hague, Netherlands) V.1-98, 1882-1979. Volume(issue)/page/year: 106,391,1987

Related Compounds

  • copper bis(3,5,5-trimethylhexanoate)
  • Copper,bis(3,5-heptanedionato-kO,kO')- (9CI)
  • Copper,bis(4-methyl-3,5-cyclohexadiene-1,2-dione 2-oximato-O,O')- (9CI)
  • Copper,bis(2-hydroxy-3,5-diiodobenzoato-O1,O2)- (9CI)
  • Copper, bis[ethyl5-[[4-(ethoxycarbonyl)-3,5-dimethyl-2H-pyrrol-2-ylidene-kN]methyl]-2,4-dimethyl-1H-pyrrole-3-carboxylato-kN1]- (9CI)
  • Copper,bis[dihydrogen2-[(4-carboxy-3,5-dimethyl-2H-pyrrol-2-ylidene)methyl]-5-chloro-4-methylpyrrole-3-carboxylato]-,tetraethyl ester (8CI)
  • methyl 5-[1-(1-aminocyclopropyl)cyclopropyl]-1-methyl-1H-pyrrole-2-carboxylate
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
  • 1-(2-Bromo-1,3-thiazol-4-yl)-2-fluoroethan-1-ol
  • tert-Butyl-DL-alanine